Newsroom

Filters: in-the-news
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Europäer zahlen zu viel für Pillen

18 July 2017

Open

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Open

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Open

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Open

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Open

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Read more

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

Read more

Biosimilar medicines: Increasing access to modern essential medicines while supporting sustainability of healthcare systems

16 February 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Read more

Biosimilar medicines. Essential for increasing access to important medicines and the sustainability of healthcare systems

25 January 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Read more

Subscribe to our newsletter